Floatz logo

Keppra

Germ Cell Tumors

Masonic Cancer Center, University of MinnesotaN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Germ Cell Tumors cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 3BB
Fludarabine
M.D. Anderson Cancer Center
Phase 1/2B
Recombinant Human Thrombopoietin
St. Jude Children's Research Hospital
Phase 1/2CCC
Car.70/Il15-Transduced Cb-Nk Cells
M.D. Anderson Cancer Center
Phase 1/2CCC
5-azacytidine
National Cancer Institute (NCI)
Phase 1/2CCC

View all 13 →

Same molecule, other indications

Keppra is also rated in:

Epilepsy, PartialDormant
A
Indicative ·
80 / 100
View asset →
Epilepsy, Tonic-clonicDormant
BBB
Indicative ·
78 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →